Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Steve Reed

Showing results (11-20 of 20) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 20 results.
Vaccine|February 22, 2014
Comparison of multiple adjuvants on the stability and immunogenicity of a clade C HIV-1 gp140 trimerJoseph P Nkolola, Ann Cheung, James R Perry, et al.
Scientific Reports|October 13, 2020
Engineering and characterization of a novel Self Assembling Protein for Toxoplasma peptide vaccine in HLA-A*11:01, HLA-A*02:01 and HLA-B*07:02 transgenic miceKamal El Bissati, Ying Zhou, Sara M Paulillo, et al.
Journal of Immunological Methods|September 16, 2019
Development of plasmonic ELISA for the detection of anti-Leishmania sp. IgG antibodiesMarilene Oliveira Dos Santos Maciel, Matheus Fujimura Soares, Sidnei Ferro Costa, et al.
Scientific Reports|August 25, 2023
Immunogenicity of a Plasmodium vivax vaccine based on the duffy binding protein formulated using adjuvants compatible for use in humansFrancisco J Martinez, Micheline Guillotte-Blisnick, Christèle Huon, et al.
NPJ Vaccines|December 22, 2017
Protein nanovaccine confers robust immunity against <i>Toxoplasma</i>Kamal El Bissati, Ying Zhou, Sara Maria Paulillo, et al.
Vaccines|September 28, 2023
CD4<sup>+</sup> T Cell Responses to <i>Toxoplasma gondii</i> Are a Double-Edged SwordKamal El Bissati, Paulette A Krishack, Ying Zhou, et al.
Heliyon|February 19, 2024
A polyvalent RNA vaccine reduces the immune imprinting phenotype in mice and induces neutralizing antibodies against omicron SARS-CoV-2Vinicius Pinto Costa Rocha, Bruna Aparecida Souza Machado, Breno Cardim Barreto, et al.
Plos One|March 2, 2023
Recombinant protein KR95 as an alternative for serological diagnosis of human visceral leishmaniasis in the AmericasMahyumi Fujimori, Ruth Tamara Valencia-Portillo, José Angelo Lauletta Lindoso, et al.
NPJ Vaccines|October 11, 2018
Malaria vaccine candidate based on Duffy-binding protein elicits strain transcending functional antibodies in a Phase I trialKavita Singh, Paushali Mukherjee, Ahmad Rushdi Shakri, et al.
Plos One|April 15, 2016
Targeting HIV-1 Env gp140 to LOX-1 Elicits Immune Responses in Rhesus MacaquesGerard Zurawski, Sandra Zurawski, Anne-Laure Flamar, et al.
Pageof 2

Showing results (11-20 of 20) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 20 results.
Vaccine|February 22, 2014
Comparison of multiple adjuvants on the stability and immunogenicity of a clade C HIV-1 gp140 trimerJoseph P Nkolola, Ann Cheung, James R Perry, et al.
Scientific Reports|October 13, 2020
Engineering and characterization of a novel Self Assembling Protein for Toxoplasma peptide vaccine in HLA-A*11:01, HLA-A*02:01 and HLA-B*07:02 transgenic miceKamal El Bissati, Ying Zhou, Sara M Paulillo, et al.
Journal of Immunological Methods|September 16, 2019
Development of plasmonic ELISA for the detection of anti-Leishmania sp. IgG antibodiesMarilene Oliveira Dos Santos Maciel, Matheus Fujimura Soares, Sidnei Ferro Costa, et al.
Scientific Reports|August 25, 2023
Immunogenicity of a Plasmodium vivax vaccine based on the duffy binding protein formulated using adjuvants compatible for use in humansFrancisco J Martinez, Micheline Guillotte-Blisnick, Christèle Huon, et al.
NPJ Vaccines|December 22, 2017
Protein nanovaccine confers robust immunity against <i>Toxoplasma</i>Kamal El Bissati, Ying Zhou, Sara Maria Paulillo, et al.
Vaccines|September 28, 2023
CD4<sup>+</sup> T Cell Responses to <i>Toxoplasma gondii</i> Are a Double-Edged SwordKamal El Bissati, Paulette A Krishack, Ying Zhou, et al.
Heliyon|February 19, 2024
A polyvalent RNA vaccine reduces the immune imprinting phenotype in mice and induces neutralizing antibodies against omicron SARS-CoV-2Vinicius Pinto Costa Rocha, Bruna Aparecida Souza Machado, Breno Cardim Barreto, et al.
Plos One|March 2, 2023
Recombinant protein KR95 as an alternative for serological diagnosis of human visceral leishmaniasis in the AmericasMahyumi Fujimori, Ruth Tamara Valencia-Portillo, José Angelo Lauletta Lindoso, et al.
NPJ Vaccines|October 11, 2018
Malaria vaccine candidate based on Duffy-binding protein elicits strain transcending functional antibodies in a Phase I trialKavita Singh, Paushali Mukherjee, Ahmad Rushdi Shakri, et al.
Plos One|April 15, 2016
Targeting HIV-1 Env gp140 to LOX-1 Elicits Immune Responses in Rhesus MacaquesGerard Zurawski, Sandra Zurawski, Anne-Laure Flamar, et al.
Pageof 2